Namodenoson, generically known as Cl-IB-MECA, is a highly selective orally bioavailable A3AR agonist that induces an apoptotic effect towards HCC in syngeneic orthotopic and xenograft experimental animal models. This evidence concerns the gene ADORA3 and hepatocellular carcinoma.